Evelyn Onaga
Critical Care Medicine · Houston, TXNPI 1194495960
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,919, 4.4 times the $435 reported in 2021.
Across 50 payments — averaging $95.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$765
- AbbVie$473
- E.r. Squibb & Sons, L.L.C.$362
- Bristol Myers Squibb$329
- Sanofi$295
- Argenx US, Inc.$284
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,787100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 7 | $765 |
| AbbVie | 9 | $473 |
| E.r. Squibb & Sons, L.L.C. | 3 | $362 |
| Bristol Myers Squibb | 3 | $329 |
| Sanofi | 2 | $295 |
| Argenx US, Inc. | 3 | $284 |
| Merck | 2 | $249 |
| Pharmacosmos Therapeutics Inc. | 2 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $145 |
| AstraZeneca | 2 | $141 |
| Sobi, Inc | 1 | $125 |
| Alcresta Therapeutics, Inc. | 1 | $124 |
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| Fresenius Kabi USA, LLC | 1 | $123 |
| La Jolla Pharmaceutical Company | 1 | $122 |
| Philips North America LLC | 1 | $118 |
| TG Therapeutics, Inc. | 1 | $112 |
| Mallinckrodt Hospital Products Inc. | 1 | $108 |
| Genentech USA, Inc. | 1 | $106 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $99 |
| Gilead | 1 | $87 |
| UCB, Inc. | 1 | $86 |
| Biogen | 2 | $86 |
| BTG International Inc. | 1 | $77 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,787 in reported general payments places this provider in the 80th percentile of 507 critical care medicine providers in Texas.
Other critical care medicine in Houston
- Edwin ParsleyHouston$283K
- Bindu AkkantiHouston$185K
- Faisal MasudHouston$155K
- Sergio Trevino CastilloHouston$133K
- Sami HossriHouston$34K
- George WilliamsHouston$33K
- Nicholas VillalobosHouston$26K
- Ranjan UpadhyayHouston$25K
- Deepa GoturHouston$23K
- Hany Abd-El MalekHouston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.